BRENNER MARTIN (Chief Scientific Officer) sold 1.6% of their position (4.18K shares) of IBIO, INC. on the open market
Open‑market sale worth $2.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 6/22/2023ACC: 0001104659-23-073578
Officer· Chief Scientific Officer
Since Jan 2021
-4.18K
Net shares
Net seller
$2.8K
Total sold
3
Open market trades
0B · 3S
3
Total transactions
4.18K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−3.86K
Price / share
$0.68
Trade value
$2.63K
% of position
1.5%
6/21/2023
257.60K→253.74K
Common Stock
Direct
Shares
−225.00
Price / share
$0.69
Trade value
$154.51
% of position
0.1%
6/21/2023
253.74K→253.51K
Common Stock
Direct
Shares
−100.00
Price / share
$0.68
Trade value
$68.32
% of position
0.0%
6/21/2023
253.51K→253.41K
Total
Net shares
−4.18K
Net value
-$2.85K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/21/2023 | S · Sale | −3.86K | $0.68 | $2.63K | 1.5% | 257.60K | 253.74K |
| Common Stock Direct | 6/21/2023 | S · Sale | −225.00 | $0.69 | $154.51 | 0.1% | 253.74K | 253.51K |
| Common Stock Direct | 6/21/2023 | S · Sale | −100.00 | $0.68 | $68.32 | 0.0% | 253.51K | 253.41K |
| Total | −4.18K | -$2.85K | ||||||
Derivative Transactions0
No derivative transactions reported